Fachrepositorium Lebenswissenschaften

2 Treffer

Kurzansicht	E-Jahr	Zugriff	Typ	Operations
The addition of bortezomib to rituximab, high-dose cytarabine and dexamethasone in relapsed or refractory mantle cell lymphoma—a randomized, open-label phase III trial of the European mantle cell lymphoma network 2024 . Fischer, Luca \| Jiang, Linmiao \| Dürig, Jan \| Schmidt, Christian \| Stilgenbauer, Stephan \| Bouabdallah, Krimo \| Solal-Celigny, Philippe \| Scholz, Christian W. \| Feugier, Pierre \| de Wit, Maike \| Trappe, Ralf Ulrich \| Hallek, Michael \| Graeven, Ullrich \| Hänel, Mathias \| Hoffmann, Martin \| Delwail, Vincent \| Macro, Margaret \| Greiner, Jochen \| Giagounidis, Aristoteles A. N. \| Dargel, Beate \| Durot, Eric \| Foussard, Charles \| Silkenstedt, Elisabeth \| Weigert, Oliver \| Pott, Christiane \| Klapper, Wolfram \| Hiddemann, Wolfgang \| Unterhalt, Michael \| Hoster, Eva \| Ribrag, Vincent \| Dreyling, Martin	2024		http://purl.org/ontology/bibo/Article
Rituximab, gemcitabine and oxaliplatin in relapsed or refractory indolent and mantle cell lymphoma: results of a multicenter phase I/II-study of the German Low Grade Lymphoma Study Group 2024 . Scheubeck, Gabriel \| Hoffmann, Martin \| Jurinovic, Vindi \| Fischer, Luca \| Unterhalt, Michael \| Schmidt, Christian \| Böck, Hans-Peter \| Dührsen, Ulrich \| Kaesberger, Joachim \| Kremers, Stephan \| Lindemann, Hans-Walter \| Mantovani, Luisa \| Hiddemann, Wolfgang \| Hoster, Eva \| Dreyling, Martin \| on behalf of the German Lymphoma Alliance (GLA)	2024		http://purl.org/ontology/bibo/Article

Suche